BOTHELL, Wash., June 4 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation's (CellCyte) (OTC Bulletin Board: CCYG) President and CEO, Gary A. Reys, will present at the 2008 San Francisco RedChip Small-Cap Investor Conference on Thursday, June 5, at 10:35 AM Pacific Daylight Time at the Palace Hotel in San Francisco. In addition, CellCyte will have a booth at the conference at which they will have a prototype demonstration of the Company's cell expansion bioreactor.
The presentation will be Web cast live with slides and archived for replay after the presentation at: http://www.redchip.com/visibility/conferencePages/SanFran2008/conferenceMai n.a sp?page=webcast
About CellCyte Genetics
CellCyte Genetics Corporation is a biotechnology company engaged in the
discovery, development and commercialization of stem cell enabling
therapeutic products. CellCyte is developing products to allow more
efficient delivery and increased retention of adult stem cells to diseased
organs, such as the heart. The goal of these therapies is to increase the
number of stem cells delivered to a damaged organ, thereby markedly
increasing organ healing and functional restoration. The Company's lead
product in development, CCG-TH30, is designed to send autologous bone
marrow-derived (adult) stem cells to the heart of patients after a heart
CellCyte Genetics | 1725 220th Street SE | Bothell | Washington | 98021 |
For further information see: http://www.cellcyte.com.
Symbol: OTCBB - CCYG; Frankfurt/Berlin Symbol - LK6 WKN. No.: A0MLCV.
|SOURCE CellCyte Genetics Corporation|
Copyright©2008 PR Newswire.
All rights reserved